Cara Therapeutics Inc (CARA)
0.293
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 13:01
Cara Therapeutics Price to Book Value: 1.386 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.404 |
| October 31, 2024 | 1.468 |
| October 30, 2024 | 1.367 |
| October 29, 2024 | 1.262 |
| October 28, 2024 | 1.277 |
| October 25, 2024 | 1.267 |
| October 24, 2024 | 1.203 |
| October 23, 2024 | 1.258 |
| October 22, 2024 | 1.272 |
| October 21, 2024 | 1.256 |
| October 18, 2024 | 1.254 |
| October 17, 2024 | 1.262 |
| October 16, 2024 | 1.253 |
| October 15, 2024 | 1.206 |
| October 14, 2024 | 1.211 |
| October 11, 2024 | 1.185 |
| October 10, 2024 | 1.200 |
| October 09, 2024 | 1.228 |
| October 08, 2024 | 1.211 |
| October 07, 2024 | 1.259 |
| October 04, 2024 | 1.303 |
| October 03, 2024 | 1.305 |
| October 02, 2024 | 1.371 |
| October 01, 2024 | 1.357 |
| September 30, 2024 | 1.456 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.442 |
| September 26, 2024 | 1.362 |
| September 25, 2024 | 1.313 |
| September 24, 2024 | 1.323 |
| September 23, 2024 | 1.423 |
| September 20, 2024 | 1.428 |
| September 19, 2024 | 1.460 |
| September 18, 2024 | 1.352 |
| September 17, 2024 | 1.263 |
| September 16, 2024 | 1.269 |
| September 13, 2024 | 1.241 |
| September 12, 2024 | 1.278 |
| September 11, 2024 | 1.388 |
| September 10, 2024 | 1.329 |
| September 09, 2024 | 1.466 |
| September 06, 2024 | 1.523 |
| September 05, 2024 | 1.518 |
| September 04, 2024 | 1.523 |
| September 03, 2024 | 1.565 |
| August 30, 2024 | 1.702 |
| August 29, 2024 | 1.662 |
| August 28, 2024 | 1.681 |
| August 27, 2024 | 1.698 |
| August 26, 2024 | 1.749 |
| August 23, 2024 | 1.646 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3789
Minimum
Dec 21 2023
6.337
Maximum
Apr 09 2021
2.906
Average
2.902
Median
Mar 25 2022
Price to Book Value Benchmarks
| Perspective Therapeutics Inc | 2.462 |
| Alaunos Therapeutics Inc | 0.8621 |
| Oragenics Inc | -- |
| Cocrystal Pharma Inc | 1.047 |
| Citius Pharmaceuticals Inc | 0.7429 |
Price to Book Value Related Metrics
| PS Ratio | 1.452 |
| Price | 0.293 |
| Earnings Yield | -696.2% |
| Market Cap | 16.07M |